Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Small Business Grants Should Help Biotechs Move Beyond Lead Products

Executive Summary

Eligibility rules for Small Business Innovation Research grants should be flexible enough to help emerging biotechnology companies develop their second or subsequent products, a biotech exec recommended at a Feb. 13 hearing of the House Small Business Committee's Subcommittee on Investigations and Oversight

You may also be interested in...



House Passes SBIR Reauthorization, Loosens Venture Capital Restrictions

A bill reauthorizing the Small Business Innovation Research program cleared the House April 23, authorizing larger research and development grants from the federal government for small companies and lifting some restrictions on venture capital backing for firms seeking such grants

House Passes SBIR Reauthorization, Loosens Venture Capital Restrictions

A bill reauthorizing the Small Business Innovation Research program cleared the House April 23, authorizing larger research and development grants from the federal government for small companies and lifting some restrictions on venture capital backing for firms seeking such grants

More VC-Backed Firms Are Eligible For SBIR Grants Under House Draft Bill

Health technology companies are making inroads toward more flexibility for venture capital-backed firms to obtain federal small business grants, based on legislation being drafted in the House Small Business Committeee

Related Content

UsernamePublicRestriction

Register

PS049322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel